How to cite this paper
Matiichuk, Y., Horak, Y., Chaban, T., Chaban, I & Matiychuk, V. (2022). Synthesis and anticancer properties of 3-furan-2-yl-2-(4-furan/thiophen-2-ylthiazol-2-yl)acrylonitrile derivatives.Current Chemistry Letters, 11(3), 269-274.
Refrences
1. Ayati A., Emami S., Asadipour A., Shafiee A., Foroumadi A. (2015) Recent Applications of 1,3-thiazole Core Structure in the Identification of New Lead Compounds and Drug Discovery. Eur. J. Med. Chem. 97 699–718.
2. Sharma P.C., Bansal K.K., Sharma A., Sharma D., Deep A. (2020) Thiazole-containing Compounds as Therapeutic Targets for Cancer Therapy. Eur. J. Med. Chem. 188 112016.
3. Jain S., Pattnaik S., Pathak K., Kumar S., Pathak D., Jain S., Vaidya A. (2018) Anticancer Potential of Thiazole Derivatives: A Retrospective Review. Mini Rev. Med. Chem. 18 (8) 640–655.
4. Kleemann A., Engel J., Kutscher B., Reichert D. (2001) Pharmaceutical substances: syntheses, patents, applications. Stuttgart, New York: Thieme. 2488.
5. Lukevits E., Demicheva L. (1993) Biological activity of furan derivatives (review). Chem. Heterocycl. Compd. 29 (3) 243–267.
6. Yadav M.R., Murumkar P., Ghuge R. (2018) Vicinal Diaryl Substituted Heterocycles 1st Edition A Gold Mine for the Discovery of Novel Therapeutic Agents, Elsevier, eBook ISBN: 9780081022498.
7. Abdou O. Abdelhamid, Ali A. Al-Atoom. (2005) 2-[4-(2-Thienyl)-1,3-thiazol-2-yl]ethanenitrile in Heterocyclic Synthesis of Biological Interist. Phosphorus Sulfur Silicon Relat. Elem. 180 (7) 1629–1646.
8. Chaban T., Matiichuk Y., Shyyka O., Chaban I., Ogurtsov V., Nektegayev I. and Matiychuk V. (2020) Synthesis, molecular docking and biological properties of novel thiazolo[4,5-b]pyridine derivatives. Acta Chim. Slov. 67 (4) 1035–1043.
9. Pokhodylo N.T., Matiychuk V.S., Obushak N.B.(2009) Synthesis of 1H-1,2,3-triazole derivatives by the cyclization of aryl azides with 2-benzothiazolylacetonone, 1,3-benzo-thiazol-2-ylacetonitrile, and (4-aryl-1,3-thiazol-2-yl)acetonitriles. Chem. Heterocycl. Compd. 45 (4) 483-488.
10. Drapak I., Foliush V., Chaban T. and Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl)thiazol-2-ylimino]thiazolidin-4-ones. Biointerface Res. Appl. Chem. 10 (3) 5507–5511.
11. Chaban T., Matiichuk Y., Сhulovska Z., Tymoshuk O., Chaban I. and Matiychuk V. (2021) Synthesis and biological evaluation of new 4-oxo-thiazolidin-2-ylidene derivatives as antimicrobial agents. Arch. Pharm. 354 (7) e2100037.
12. Tymoshuk O., Oleksiv L., Khvalbota L., Chaban T. and Patsay I. (2019) Spectrophotometric determination of Ru(IV) using 5-hydroxyimino-4-imino-1,3-thiazolidin-2-one as a novel analytical reagent. Acta Chim. Slov. 66 (1) 62–69.
13. Chaban T., Matiychuk V., Mahlovanyy A., Chaban I., Ogurtsov V. and Leluykh M. (2020) Synthesis and biological evaluation of 1-(3-chloro-2-oxo-4-phenylazetidin-1-yl)-3-(2-oxo-2-(10H-phenothiazin-10-yl)ethyl)urea derivatives. Biointerface Res. Appl. Chem. 10 (4) 5944–5950.
14. Pokhodylo N., Teslenko Y., Matiychuk V. and Obushak M. (2009) Synthesis of 2,1-benzisoxazoles by nucleophilic substitution of hydrogen in nitroarenes activated by the azole ring. Synthesis. 16 2741-2748.
15. Rydchuk P., Tymoshuk O., Oleksiv L., Chaban T. and Matiychuk V. (2019) Voltammetric Determination of Pt(IV) using 5-Hydroxyimino-4- imino-1,3-thiazolidine-2-one. Methods Objects Chem. Anal. 14 (3) 130–139.
16. Chaban T. Matiichuk Y., Horishny V., Chaban I. and Matiychuk V. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem. 56 (5) 813–818.
17. Сhulovska Z., Chaban T., Drapak I., Chaban I. and Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem. 11 (1) 8009–8017.
18. Pokhodylo N.T., Matiychuk V.S., Obushak M.D. (2009) Synthesis of triazoles via regioselective reactions of aryl azides with cyanoacetyl pyrroles and indoles. Synthesis. 8 1297–1300.
19. Chaban T., Matiychuk V., Ogurtsov V., Chaban I. and Nektegayev I. (2020) Development of effective anti-inflammatory drug candidates among novel thiazolopyridines. Ukr. Biochem. J. 92 (2) 132–139.
20. Obushak N.D., Lesyuk A.I., Gorak Y.I., Matiichuk V.S. (2009) Mechanism of Meerwein arylation of furan derivatives. Russ. J. Org. Chem. 45 (9) 1375–1381.
21. Obushak N.D., Gorak Y.I., Matiichuk V.S., Lytvyn R.Z. (2008) Synthesis of heterocycles based on arylation products of unsaturated compounds: XVII. Arylation of 2-acetylfuran and synthesis of 3-R-6-(5-aryl-2-furyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines. Russ. J. Org. Chem. 44 (11) 1689–1694.
22. Developmental Therapeutics Program. Available online: http://dtp.nci.nih.gov.
23. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A. (1991) Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. J. Nat. Cancer Inst. 83 (11) 757-766.
24. Boyd M. R., Paull K. D. (1995) Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev. Res. 34 (1) 91-109.
25. Shoemaker R. H. (2006) The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6 (10) 813-823.